Postpartum Depression

Postpartum Depression: Complete Guide to Symptoms & Treatment

Becoming a parent is a profound life transition, but for many new mothers, this period brings unexpected emotional challenges. Postpartum depression (PPD) is a serious medical condition affecting up to 1 in 5 new mothers, yet many women suffer in silence, believing their symptoms are normal or temporary. At KwikPsych in Austin, we specialize in diagnosing and treating postpartum depression with compassionate, evidence-based care.

This guide explains what postpartum depression is, how it differs from related conditions, and the treatment options available—including approaches specifically tailored for breastfeeding mothers.

What Is Postpartum Depression?

Postpartum depression is a clinical mood disorder that develops in the weeks or months following childbirth. Unlike the temporary emotional adjustment many new mothers experience, postpartum depression is characterized by persistent depressive symptoms that significantly interfere with daily functioning, bonding with the baby, and overall well-being.

The DSM-5 diagnostic criteria recognize postpartum depression as a major depressive episode with peripartum onset when symptoms begin during pregnancy or within four weeks of delivery. However, clinical experience shows that postpartum depression can develop anytime within the first year after birth, with most cases emerging within the first three months.

Postpartum Depression vs. Baby Blues vs. Other Perinatal Conditions

It's critical to distinguish postpartum depression from similar but distinctly different conditions:

Postpartum Blues

• Timeline: Appears within first few days after birth, peaks around days 3-5
• Duration: Resolves spontaneously within 2 weeks
• Symptoms: Mild sadness, crying, mood changes, irritability, anxiety, fatigue
• Severity: No suicidal thoughts or psychotic features; minimal functional impairment
• Prevalence: Affects up to 80% of new mothers
• Clinical significance: Normal postpartum adjustment, not a disorder; no treatment typically required

Postpartum Depression

• Timeline: Usually emerges in first 3 months (based on published surveillance data, 54% occur in month 1, 40% in months 2-4)
• Duration: Persists for weeks to months without treatment
• Symptoms: Depressed mood, loss of interest, guilt, fatigue, sleep disturbance (beyond normal newborn disruption), concentration problems, sometimes thoughts of harming self or baby
• Severity: Causes significant functional impairment; affects work, relationships, parenting, and self-care
• Prevalence: Up to 1 in 5 (approximately 20%) of postpartum women
• Clinical significance: A treatable psychiatric disorder requiring professional intervention

Postpartum Anxiety Disorder

• Symptoms: Excessive worry, panic attacks, restlessness, physical anxiety symptoms
• Focus: Often centered on infant safety, health concerns
• Timeline: May occur alongside or separately from depression
• Prevalence: 10-15% of postpartum women; can co-occur with depression

Postpartum Psychosis

• Timeline: Typically develops within first 2 weeks postpartum
• Symptoms: Delusions, hallucinations, disorganized thinking, severe mood episodes
• Severity: Psychiatric emergency requiring immediate hospitalization
• Prevalence: Rare (0.1-0.2% of births) but requires urgent treatment
• Clinical significance: Requires psychiatric hospitalization and medication management

Symptoms of Postpartum Depression

Postpartum depression presents with the same core symptoms as major depression, but the postpartum context requires careful evaluation. A key challenge is distinguishing depression symptoms from normal postpartum changes (sleep disruption from infant care, appetite changes, fatigue).

Core Symptoms

To meet diagnostic criteria for postpartum depression, a woman must experience at least 5 of these symptoms, present most days for at least 2 weeks:

• Persistent depressed mood throughout the day, most days
• Loss of interest or pleasure (anhedonia) in activities that previously brought joy
• Significant changes in appetite or weight (eating much more or less)
• Sleep disturbance that cannot be attributed entirely to infant care (difficulty falling/staying asleep even when baby is sleeping, or excessive sleeping)
• Fatigue or loss of energy so severe that getting out of bed or completing daily tasks feels overwhelming
• Feelings of worthlessness or excessive, inappropriate guilt
• Difficulty concentrating or making decisions
• Psychomotor agitation or retardation (observable to others)
• Thoughts of death or suicide, or thoughts of harming the baby

Severity Spectrum

Mild to Moderate Postpartum Depression

• 5-6 symptoms present
• Patient Health Questionnaire (PHQ-9) score <20
• Edinburgh Postnatal Depression Scale (EPDS) score approximately 11-15
• Functional impairment present but patient can manage some daily tasks
• No suicidal behavior or psychotic features
• Can typically be managed in outpatient or partial hospitalization settings

Severe Postpartum Depression

• 7-9 symptoms, nearly every day
• PHQ-9 score ≥20
• EPDS score ≥20
• Substantial functional impairment (unable to care for self or infant)
• Suicidal ideation or behavior
• Possible psychotic features
• Requires psychiatric hospitalization and close monitoring

Risk Factors for Postpartum Depression

Research has identified numerous risk factors that increase vulnerability to postpartum depression. Understanding your risk profile helps with early screening and prevention.

Primary Risk Factors

Depression During Pregnancy

• Strongest predictor of postpartum depression
• Women depressed during pregnancy are 4-5 times more likely to develop postpartum depression
• Suggests underlying vulnerability to mood disorders in peripartum period

Prior History of Depression

• Previous depressive episodes (perinatal or non-perinatal) significantly increases risk (3-5 fold)
• Personal history of mood disorders indicates need for closer monitoring
• May warrant preventive treatment considerations

Secondary Risk Factors

Psychosocial Stressors

• Marital conflict or relationship problems
• Loss or major life changes (moving, job loss, death of loved one)
• Financial stress
• Lack of partner or family support
• Social isolation
• Recent trauma or abuse

Circumstantial Factors

• Poor social support or isolation
• Limited financial resources
• Complications during pregnancy or delivery
• Infant health problems or prematurity
• Multiple births (twins/multiples)
• Recent immigration or major life transitions

Biological/Hormonal Factors

• History of premenstrual dysphoric disorder (PMDD)
• History of bipolar disorder (increased risk of postpartum mood episodes)
• Thyroid dysfunction postpartum
• Sleep deprivation (a significant risk factor in its own right)

Demographic Factors

• First-time motherhood
• Maternal age (some studies show increased risk in younger mothers)
• Single parenthood

Risk Assessment

If you experience multiple risk factors—especially depression during pregnancy combined with poor social support—proactive screening and early intervention become essential. At KwikPsych, we recommend discussing risk factors with Dr. Thangada during pregnancy or immediately after delivery.

Screening for Postpartum Depression

Early detection dramatically improves outcomes. Multiple validated screening tools can identify postpartum depression before it becomes severe.

Edinburgh Postnatal Depression Scale (EPDS)

The EPDS is the gold standard screening tool used worldwide and in clinical practice at KwikPsych.

How it works: 10 self-report questions about mood, anxiety, guilt, and suicidal thoughts over the past 7 days.

Scoring:

• 0-9: Unlikely to have postpartum depression
• 10-12: Possible postpartum depression; recommend clinical assessment
• 13+: Probable postpartum depression; clinical evaluation essential
• 15+: Moderate to severe depression

When administered: Standard screening occurs at 2 weeks, 6 weeks, and 3 months postpartum, though screening can occur anytime within the first year.

Limitations: EPDS is a screening tool, not a diagnostic instrument. A positive screen requires clinical interview with a psychiatrist to confirm diagnosis.

Patient Health Questionnaire-9 (PHQ-9)

The PHQ-9 is a 9-item depression severity scale that corresponds to DSM-5 diagnostic criteria.

Scoring:

• 0-4: Minimal depression
• 5-9: Mild depression
• 10-14: Moderate depression
• 15-19: Moderately severe depression
• 20+: Severe depression

Advantage: Directly maps to depression severity, which helps guide treatment decisions (mild-moderate vs. severe).

When to Screen

The American Psychiatric Association and American College of Obstetricians and Gynecologists recommend:

• Screening at hospital discharge or within first 2 weeks postpartum
• Routine screening at 6-week postpartum follow-up visit
• Continued monitoring through first year postpartum
• More frequent screening if risk factors present

If you experience symptoms between scheduled screenings, contact your healthcare provider immediately rather than waiting.

How KwikPsych Diagnoses Postpartum Depression

Diagnosis requires more than a screening scale—it requires comprehensive clinical evaluation by a psychiatrist. Dr. Monika Thangada, MD, conducts thorough diagnostic assessments for postpartum depression.

Comprehensive Evaluation Includes

Clinical Interview

• Detailed symptom history: when symptoms began, progression, severity, impact on functioning
• Context about childbirth, recovery, infant health, and support systems
• Screening for suicidal or infanticidal ideation (crucial safety assessment)
• Assessment of anxiety, panic, and intrusive thoughts
• Inquiry about previous depressive or manic episodes

Symptom Severity Assessment

• Use of validated scales (EPDS, PHQ-9) to quantify severity
• Evaluation of functional impairment across work, relationships, parenting, self-care
• Assessment of sleep, appetite, concentration, energy levels

Medical Rule-Out

• Thyroid function testing (postpartum thyroiditis can mimic depression)
• Comprehensive metabolic panel
• Assessment for perinatal mood/anxiety disorder vs. bipolar disorder
• Review of medications that could contribute to depression

Contextual Factors

• Relationship quality and partner support
• Infant health and sleep patterns
• Family history of mental illness
• Previous treatment response to antidepressants or therapy
• Breastfeeding status and plans

Safety Assessment

• Direct inquiry about suicidal thoughts
• Assessment of thoughts about harming infant
• Evaluation of access to means
• Assessment of protective factors

Once diagnosis is confirmed, Dr. Thangada develops an individualized treatment plan based on severity, preferences, and circumstances.

Treatment for Postpartum Depression

Evidence supports multiple effective treatment approaches for postpartum depression. The choice of treatment depends on severity, preferences, breastfeeding status, and previous treatment response.

Psychotherapy as First-Line Treatment

For mild to moderate postpartum depression, psychotherapy is recommended as initial treatment, particularly for mothers who prefer to avoid medications or who are breastfeeding.

Evidence: Meta-analyses show that cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT) modified for postpartum populations are significantly more effective than usual care:

• 70% of patients in therapy achieve remission vs. 35% in control groups
• Improvement rates approximately 30% higher than usual care
• Benefits persist beyond end of treatment

KwikPsych Approach: Our trained therapists on staff deliver evidence-based psychotherapy modalities including:

Cognitive-Behavioral Therapy (CBT) for Postpartum Depression

• Identifies connections between thoughts, feelings, and behaviors
• Challenges negative thought patterns specific to motherhood and baby care
• Develops behavioral activation strategies to counter inactivity and withdrawal
• Practical problem-solving for common postpartum challenges
• Typically 12-16 sessions
• Highly effective for mild to moderate symptoms

Interpersonal Therapy (IPT) for Postpartum Depression

• Focuses on relationship patterns and interpersonal problems
• Addresses role transitions inherent in becoming a mother
• Improves communication and social support
• Works with grief and loss associated with life changes
• Typically 12-16 sessions
• Particularly effective for depression linked to relationship or support issues

Supportive Psychotherapy

• Validation of the difficulty of postpartum period
• Psychoeducation about postpartum depression
• Support for parenting challenges and self-care
• Can be combined with other treatments

Frequency: Therapy typically occurs weekly for mild to moderate depression, with gradual spacing as symptoms improve.

Antidepressant Medications for Postpartum Depression

When psychotherapy alone is insufficient, or for moderate to severe depression, antidepressants are highly effective. For postpartum women, particularly those breastfeeding, certain medications are safer than others.

First-Line SSRIs (Selective Serotonin Reuptake Inhibitors)

SSRIs are the most widely used and best-studied antidepressants for postpartum depression, with extensive safety data during breastfeeding.

Sertraline (Zoloft)

• Status: First-line choice for postpartum depression, especially in breastfeeding mothers
• Dosing: Typical range 50-200 mg daily
• Advantages: Minimal infant exposure through breast milk; among lowest levels found in infant serum; extensive safety data; relatively rapid onset (2-4 weeks)
• Side effects: Nausea, decreased libido, insomnia, gastrointestinal upset
• Half-life: 26 hours (moderate clearance from system)
• Breastfeeding: Relative infant dose <0.5% (minimal exposure)

Paroxetine (Paxil)

• Status: First-line alternative, particularly safe during breastfeeding
• Dosing: Typical range 20-60 mg daily
• Advantages: Low infant exposure through breast milk; extensive safety data; good efficacy
• Side effects: Sexual dysfunction, weight gain, withdrawal difficulty
• Breastfeeding: Relative infant dose <0.5% (minimal exposure)

Citalopram (Celexa)

• Status: Acceptable option; slightly higher infant exposure than sertraline/paroxetine
• Dosing: Typical range 20-40 mg daily
• Advantages: Good efficacy, once-daily dosing
• Concern: Slightly higher infant serum concentrations; FDA recommends maximum 20 mg daily in women >60 years due to QT prolongation risk (less relevant to postpartum women)
• Breastfeeding: Relative infant dose approximately 0.5-2% (low but measurable)

Fluoxetine (Prozac)

• Status: Generally acceptable but less preferred initially due to longer half-life
• Dosing: Typical range 20-60 mg daily
• Advantages: Longer half-life provides coverage if dose missed; extensive data
• Concern: Longer half-life (24-72 hours) means drug accumulates in infant system over time
• Breastfeeding: Relative infant dose 0.5-2% (acceptable but higher than sertraline)
• Consideration: May be preferred if planning to discontinue breastfeeding or if patient previously responded to fluoxetine

Other SSRIs

Escitalopram (Lexapro)

• Similar profile to citalopram with lower infant exposure
• Good tolerability
• Typical dosing 10-20 mg daily

Sertraline vs. Other SSRIs: Clinical Reality

In clinical practice, sertraline is most often recommended for postpartum depression during breastfeeding because:

• Lowest reported infant serum concentrations
• Decades of clinical experience specifically in postpartum patients
• Best-studied during breastfeeding
• Rapid onset of action
• Favorable side effect profile for many patients

However, if a mother has previously responded well to fluoxetine or paroxetine, continuing the same medication is often preferred, as switching introduces risk of treatment failure.

Newer Rapid-Acting Treatments

Brexanolone (Zulresso)

• Status: FDA-approved specifically for postpartum depression (2019)
• Mechanism: GABA_A receptor positive allosteric modulator; mimics natural neurosteroid changes in pregnancy
• Administration: 60-hour IV infusion in clinical setting
• Onset: Rapid (24-48 hours); faster than traditional antidepressants
• Efficacy: Significant symptom reduction by day 3-5 of infusion
• Use in breastfeeding: Appears safe based on limited data; careful monitoring recommended
• Limitations: Requires hospitalization/clinic-based infusion; cost; limited availability
• Candidates: Primarily for moderate-severe depression where rapid response crucial; particularly useful when severe suicidal ideation present

Zuranolone (Zurzuvae)

• Status: FDA-approved (2023); oral version of brexanolone
• Administration: Oral tablets, 14-day course
• Onset: Rapid response (days 3-5)
• Advantages: Oral formulation, shorter course than traditional SSRIs, rapid onset
• Breastfeeding: Safety profile appears favorable but requires discussion with pediatrician
• Emerging option: Represents significant advancement for women seeking rapid relief

SSRIs for Severe Postpartum Depression: While therapy is first-line for mild-moderate depression, severe postpartum depression typically requires immediate medication initiation combined with psychotherapy. Many severe cases require hospitalization and close monitoring, particularly if suicidal ideation or thoughts of harming baby present.

Other Antidepressant Classes

Tricyclic Antidepressants (Amitriptyline, Nortriptyline)

• Less commonly used first-line for postpartum depression
• More side effects than SSRIs (sedation, dry mouth, constipation)
• May be considered if previous positive response
• Safe during breastfeeding
• Require monitoring of levels and cardiac effects in some cases

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs: Venlafaxine, Desvenlafaxine)

• Generally acceptable for postpartum depression
• May be preferred if also treating anxiety
• Venlafaxine has higher infant serum levels; desvenlafaxine lower
• Consider if SSRI alone insufficient or if previous SNRI response

Atypical Antidepressants (Bupropion, Mirtazapine)

• Bupropion: Lower breastfeeding exposure; may be preferred; no sexual side effects; stimulating (caution with anxiety); lower seizure risk than historical rates
• Mirtazapine: Sedating (useful if insomnia significant); generally safe during breastfeeding; can promote weight gain

Medication Safety During Breastfeeding

Key Principles

The benefits of breastfeeding and effective maternal treatment generally outweigh small risks from medication exposure:

• Breastfeeding provides significant benefits to infant (immune factors, bonding, nutrition)
• Antidepressant exposure through breast milk is typically 5-10 times lower than fetal exposure during pregnancy (varies by medication; discuss with your psychiatrist)
• If mother was successfully treated during pregnancy, continuing same medication prevents maternal relapse and neonatal withdrawal
• Most antidepressants result in minimal detectable infant serum levels
• Adverse effects in breastfed infants exposed to antidepressants are uncommon

Monitoring During Breastfeeding

If continuing antidepressants while breastfeeding:

• Pediatrician should establish baseline infant behavior, feeding, sleep, and alertness
• Monthly monitoring for adverse effects: irritability, agitation, crying, poor feeding, sleep disturbances, poor weight gain
• If adverse effects suspected, contact mother's psychiatrist and infant's pediatrician immediately
• Routine infant serum drug levels not recommended but can be helpful if adverse effects suspected
• Infant serum levels showing minimal drug exposure can reassure anxious mothers

Medication Administration Tips

Do NOT:

• Time medication taking to "minimize" infant exposure (not evidence-based)
• Discard breast milk after taking medication (impractical, no evidence)

Instead:

• Take medication consistently as prescribed
• Prioritize maternal mental health and treatment adherence
• Discuss specific medication timing questions with psychiatrist if concerned

Managing Sleep While Breastfeeding

Sleep deprivation significantly exacerbates postpartum depression and anxiety. Strategies to protect sleep while maintaining breastfeeding:

• Express/pump breast milk during day to allow partner to do nighttime bottle-feeds
• Take one uninterrupted 4-5 hour sleep block while partner feeds expressed milk
• If inadequate pumped supply, formula feeding for one designated bottle is acceptable
• The goal is balancing successful breastfeeding with adequate maternal sleep

Combination Treatment: Therapy + Medication

For moderate to severe postpartum depression, or when either therapy or medication alone proves insufficient, combining psychotherapy with antidepressants is highly effective:

• More effective than either treatment alone
• Allows lower medication doses
• Addresses both symptom relief and underlying patterns
• Provides multiple treatment modalities for different symptom domains
• Reduces relapse risk

At KwikPsych, we coordinate care between psychiatric medication management and therapy services, ensuring integrated treatment.

Partner and Family Support

The postpartum period is not solely the mother's burden—partners and family play crucial roles in recovery from postpartum depression.

For Partners

Recognize the Signs

• Understand that postpartum depression is an illness, not weakness or poor mothering
• Learn the difference between baby blues and postpartum depression
• Watch for persistent depressed mood, withdrawal, difficulty bonding with baby, inability to concentrate, or statements about worthlessness

Provide Practical Support

• Share nighttime responsibilities to protect mother's sleep
• Handle infant care tasks when mother needs rest or for therapy appointments
• Manage household tasks, cooking, cleaning
• Provide uninterrupted time for mother to shower, rest, walk alone
• Attend medical appointments when possible

Provide Emotional Support

• Listen without judgment or attempts to "fix" the problem
• Validate the difficulty of postpartum period
• Avoid statements like "just think positive" or "you should be happy"
• Encourage professional help and support treatment adherence
• Maintain expressions of love and attraction to counter depression-induced worthlessness feelings

Manage Partner's Mental Health

• Partners can also experience postpartum depression (10% of postpartum fathers develop depression)
• Postpartum anxiety in partners is common
• If partner struggling, encourage professional help for both

Safety Planning

• If mother expresses thoughts of harming herself or baby, take seriously
• Assist with safety planning and crisis management
• Know when to call 911 or crisis line

For Family Members

• Provide meals, helping with household tasks
• Offer childcare support without criticism
• Provide companionship without judgment
• Encourage medical treatment
• Respect privacy and treatment decisions

FAQs About Postpartum Depression

Q: How long does postpartum depression last without treatment?

A: Without treatment, postpartum depression can persist for months to years. Some studies suggest average duration of 6 months if untreated, but many women struggle for longer. Early treatment significantly shortens duration and prevents chronic depression. With effective treatment (therapy and/or medication), most women achieve remission within 2-4 weeks of initiating care.

Q: Can I have postpartum depression if I'm not breastfeeding?

A: Yes, absolutely. Postpartum depression is not related to breastfeeding status. Depression occurs in formula-feeding mothers at similar rates. Some women stop breastfeeding due to depression symptoms, which is a valid decision. Others feel pressure to breastfeed despite depression. Both choices are medically acceptable.

Q: Is postpartum depression my fault? Did something I did cause this?

A: No. Postpartum depression is a medical condition caused by combination of biological, hormonal, psychological, and social factors—not by anything the mother did or didn't do. The hormonal changes after birth, previous depression history, genetic factors, and life circumstances all contribute. This is not caused by inadequate love for the baby or poor parenting. Treatment is the appropriate response.

Q: Will postpartum depression affect my baby?

A: Untreated postpartum depression can affect infant development and mother-infant bonding, including reduced interaction, delayed cognitive development, and behavioral problems. However, treatment of the mother's depression protects the infant. Effective maternal treatment is one of the most important things for infant well-being.

Q: Can I take antidepressants while breastfeeding?

A: Yes, for most antidepressants, particularly SSRIs like sertraline. Infant exposure through breast milk is typically minimal. The risks of untreated depression to you and your baby generally outweigh the small risks from medication exposure. Discuss specific medications with your psychiatrist and pediatrician.

Q: How quickly will I feel better on antidepressants?

A: SSRIs typically take 2-4 weeks to show noticeable improvement, with fuller response by 6-8 weeks. Newer treatments like brexanolone and zuranolone show improvement within days. Psychotherapy effects vary but typically noticeable improvement within 4-6 sessions. You don't have to wait—contact Dr. Thangada now.

Q: If I had postpartum depression with my first child, will I get it again?

A: History of postpartum depression approximately doubles risk in subsequent pregnancies. However, knowledge is power—with proactive screening, preventive treatment considerations, and early intervention, many women avoid recurrence or experience milder episodes. Discuss prevention strategies with your psychiatrist during pregnancy planning.

Q: Can postpartum depression be prevented?

A: For high-risk women (previous depression, depression during pregnancy, multiple risk factors), preventive approaches include psychotherapy, psychoeducation, and sometimes preventive medication started immediately postpartum or during late pregnancy. Discuss personalized prevention strategies with Dr. Thangada.

Q: What if therapy or medication isn't working?

A: Treatment response typically requires adequate dose and sufficient time (6-8 weeks minimum for medication, 8-12 sessions for therapy). If not responding: (1) ensure adherence to treatment plan, (2) assess for other conditions (thyroid dysfunction, bipolar disorder, anxiety disorder), (3) consider medication adjustment (dose increase, switch, or addition), (4) consider hospitalization if safety concerns. Contact Dr. Thangada immediately if not improving.

Q: Will I always have postpartum depression?

A: No. With appropriate treatment, most women achieve full recovery. Some women are at higher risk for future depressive episodes (particularly those with lifelong history of depression), but postpartum depression specifically is highly treatable. The earlier treatment begins, the faster recovery.

Q: Should I take my baby to a separate room while taking medication?

A: No. There is no need to separate from your baby while taking antidepressants. Infant exposure through breast milk (if breastfeeding) or living in the home is safe with properly prescribed medications. Separation can increase depression and interfere with bonding. Stay with your baby while receiving treatment.

When to Seek Urgent Care

Contact emergency services (911) or go to the emergency room immediately if you experience:

• Suicidal thoughts or plans
• Thoughts of harming your baby
• Inability to care for yourself or your baby
• Severe panic or anxiety with physical symptoms suggesting heart attack
• Hallucinations or delusions
• Extreme agitation or recklessness

If you or someone you know is in crisis, call 911 or the Suicide & Crisis Lifeline at 988, or text HOME to 741741 (Crisis Text Line).

Contact your psychiatrist immediately (same day) if you experience:

• New or worsening suicidal ideation
• Increasing hopelessness or withdrawal
• New thoughts about harming baby
• Severe insomnia (unable to sleep despite opportunity)
• Significant symptom worsening

Contact KwikPsych for Postpartum Depression Treatment

At KwikPsych, Dr. Monika Thangada specializes in comprehensive postpartum depression diagnosis and treatment. Our integrated approach combines psychiatric medication management with on-staff therapy services, providing coordinated care tailored to your needs.

Dr. Monika Thangada, MD

Board-Certified MD Psychiatrist

Specializing in Perinatal Mental Health

Location: 12335 Hymeadow Dr, Suite 450, Austin, TX 78750

Phone: (737) 367-1230

Telehealth: Available throughout Texas

Services Include:

• Comprehensive psychiatric evaluation and diagnosis
• Medication management with special attention to breastfeeding safety
• Individual psychotherapy (CBT, IPT, supportive)
• Crisis intervention and hospitalization coordination
• Family psychoeducation

Insurance Accepted: Aetna, BCBS, Cigna, UnitedHealthcare, Superior HealthPlan/Ambetter, Baylor Scott & White, Oscar, Optum, Medicare

Self-Pay Options: $299 initial consultation / $179 follow-up visits

Payment Methods: Cash, check, Visa, Mastercard, American Express, Discover

Don't wait. Postpartum depression is highly treatable, and early intervention leads to faster recovery. Reach out to KwikPsych today.

Medical Disclaimer: This content is educational and should not replace professional medical evaluation. If you are experiencing symptoms of postpartum depression, please consult with a qualified healthcare provider for proper diagnosis and treatment. If you or someone you know is in crisis, call 911 or the Suicide & Crisis Lifeline at 988, or text HOME to 741741 (Crisis Text Line).

Related Resources at KwikPsych

• Postpartum Depression Treatment Services
• Postpartum Depression Evaluation & Medication Management
• Postpartum Depression vs. Baby Blues: What's the Difference?
• Postpartum Depression in Partners & Fathers
• Postpartum Anxiety: Symptoms and Treatment